APOE epsilon 4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults

Simone Hollands; Yen Ying Lim; Simon M Laws; Victor L Villemagne; Robert H Pietrzak; Karra Harrington; Tenielle Porter; Peter Snyder; David Ames; Christopher Fowler; Stephanie R Rainey-Smith; Ralph N Martins; Olivier Salvado; Joanne Robertson; Christopher C Rowe; Colin L Masters; Paul Maruff

Journal article

APOE epsilon 4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults

Simone Hollands, Yen Ying Lim, Simon M Laws, Victor L Villemagne, Robert H Pietrzak, Karra Harrington, Tenielle Porter, Peter Snyder, David Ames, Christopher Fowler, Stephanie R Rainey-Smith, Ralph N Martins, Olivier Salvado, Joanne Robertson, Christopher C Rowe, Colin L Masters, Paul Maruff

Journal of Alzheimer's Disease | IOS PRESS | Published : 2017

DOI: 10.3233/JAD-161019

University of Melbourne Researchers

Yen Ying Lim Author Florey Department of Neuroscience and Mental Health

Colin Masters Author Florey Department of Neuroscience and Mental Health

Christopher Rowe Author Medicine - Austin Health

David Ames Author Psychiatry

Victor Villemagne Author Medicine - Austin Health

Grants

Funding Acknowledgements

Funding for the study was provided in part by the study partners (Common wealth Scientific Industrialand research Organization [CSIRO], Edith Cowan University [ECU], Mental Health Research institute [MHRI], National Ageing Research Institute[NARI], Austin Health, CogState Ltd). The study also received support from the National Health and Medical Research Council (NHMRC) and the Dementia Collaborative Research Centres program (DCRC2), as well as funding from the Science and Industry Endowment Fund (SIEF) and the Cooperative Research Centre (CRC) for Mental Health, an Australian Government Initiative.